Psilocybin is a naturally occurring psychedelic compound that is being studied as a potential therapy for psychological distress and depression. In this trial, it is being investigated as a treatment for patients with serious medical conditions (COPD, ALS, MS, or APD) who are experiencing depression. The therapy involves administering psilocybin in different doses along with psychological support to help patients process their experiences and potentially reduce their depressive symptoms.

Chronic Obstructive Pulmonary Disease (COPD) – A progressive lung condition that makes breathing difficult due to narrowed airways and damaged lung tissue. The airways become inflamed and thickened, while air sacs lose their elastic quality. This causes symptoms like shortness of breath, chronic cough, and excess mucus production.

Amyotrophic Lateral Sclerosis (ALS) – A neurological condition affecting nerve cells that control voluntary muscle movement. The disease causes progressive weakness in muscles used for moving, speaking, eating, and breathing. Over time, the muscles become smaller and weaker as motor neurons degenerate.

Multiple Sclerosis (MS) – A condition where the immune system affects the protective covering of nerve fibers in the central nervous system. This disruption of nerve signals can cause various symptoms including fatigue, difficulty walking, vision problems, and muscle weakness. The disease can progress in different patterns.

Multiple System Atrophy (MSA) – A neurological disorder that affects multiple parts of the nervous system. It causes problems with movement, balance, and automatic body functions. Symptoms typically include poor coordination, fainting spells, and difficulties with speech and swallowing.

Progressive Supranuclear Palsy (PSP) – A brain disorder that affects movement, balance, speech, and vision. The condition causes gradual deterioration of brain cells in specific areas. People experience difficulties with walking, balance, and eye movements.

Corticobasal Syndrome (CBS) – A neurological condition affecting both movement and cognitive functions. It typically begins on one side of the body with stiffness, shakiness, and difficulty controlling arm or leg movements. The condition gradually affects both sides of the body and can impact speech and comprehension.